Haven’t seen much if any talk on this group on WSO. From what I’ve heard it’s sweatier than other BB coverage groups as there’s less product group support.
Anyone know about this group, in terms of exits, culture, deal flow etc?
| +255 | Why UBS Is the Worst Place to Start Your IB Career | 39 | 16m |
| +213 | UBS 2nd Year Analyst Q&A (2026) | 38 | 5h |
| +70 | Firm Thinks I'm Lying About Offer | 20 | 2d |
| +65 | What's your craziest "hardo" story? | 11 | 15m |
| +62 | Indiana University Fraternity Pipelines | 36 | 1d |
| +51 | Rogo AI | 21 | 6h |
| +49 | Elite Boutique interview questions | 17 | 1h |
| +47 | Suspended for a Year | 19 | 1d |
| +40 | Stay at Weak Dealflow Team or Lateral? | 12 | 3d |
| +26 | Wolf of Wall Street vs. Reality: Anyone else feel scammed by the movies? | 9 | 9h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
following
Following
del
Also curious
No Morgan Stanley HC bankers on this forum?
Seems not - seems to place well exit-wise, although I only have n=1, MS HC -> Blackstone Life Sciences
I know they worked on Merck-Prometheus. The one guy I talked to there was a nice guy, but other than that I don’t know much. CVP or JPM is probably better deal wise but honestly you can’t go wrong with MS.
Agreed- think they also worked on Amgen-Horizon and are on some PE type deals with royalty Pharma and BXLS
Amgen-Horizon was the SF group I believe. I know SF has Amgen on account.
.
Thank you! This is definitely the most helpful piece of insight on this forum, am really learning more about this group so I thank you!
I know you covered a lot, but if I had to just add another follow up- did you notice anyone exiting into Biotech investing (HF or Royalty PE type)?
Biotech is arguably the strongest part of the franchise imo; quite a few of the best biotech IPOs / FOs recently have been done by this group, and very strong in biopharma M&A as well. See rainmakers like Clint Gartin (over a fucking trillion in M&A volume, total baller whose son was opposite him at Citi on Bristol) and Joe Modisett.
Tbh the biopharma subvertical within MS HC kinda does their own thing and has their choice of analysts because it's so dominant, but pretty much anyone that even remotely wants to do biotech gets some of those staffings. Just pray you don't get assigned the biotech update internal staffing lol
Sorry, to actually answer your question-- I did a few biotech deals and have practically gotten harassed by some of the major biotech funds to interview. If you're interested in Sixth Street, RA Capital, Deerefield etc. you will have a very very easy time compared to p much any other coverage group on the street. The story makes total sense, the work is transferrable, and there's a very strong pipeline historically. Like I said-- focus on getting into the group first, because it can be pretty competitive
To be specific, would you say this covers just MS HC NY or is the SF group at the same level as well? Thanks
How them bonus numbers tho LMAO. Brokie out here coping
attractive analysts, mainly girls
.
It is sweatier, but Healthcare is a sweaty group across banks. Having worked at two IBs, I wouldn't say that HC at MS is particularly worse than it is anywhere else. Generally the internal BS items are easier at MS than other places (credit committees, equity committees, etc.) so most of your time is spent on client-facing work, which is definitely a plus
Culture-wise the group is pretty solid - no overwhelmingly difficult personalities and everyone is generally friendly
Disagree. Group has toxic culture. Vindictive, conniving seniors. Highest turnover at MS.
Avoid at all costs if possible.
Harum sed quaerat quibusdam corrupti quia. Occaecati laboriosam voluptatem quod sed aut blanditiis sit. Delectus optio ut suscipit id omnis illo blanditiis. Voluptates eum atque quia dolores iure.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Perspiciatis et doloremque hic aut unde. Ea aliquam autem et occaecati amet. Voluptatem error voluptas quam omnis blanditiis nulla id.
Rem nam molestiae debitis aut. Quas earum facere eos modi. Consequatur quia sed quis saepe voluptatem. Ratione voluptatem saepe et perspiciatis ducimus inventore facilis.